posted on 2017-08-16, 09:01authored byS. Ziya, Nick Medcalf, Alicia J. El Haj, K.T. Wright
Facilitating the operational readiness of the NHS for the in-house manufacture and delivery of autologous cell therapy [210]
History
School
Mechanical, Electrical and Manufacturing Engineering
Published in
CYTOTHERAPY
Volume
19
Issue
5
Pages
S89 - S89
Citation
ZIYA, S. ... et al, 2017. Facilitating the operational readiness of the NHS for the in-house manufacture and delivery of autologous cell therapy [210]. Cytotherapy, 19 (5), Supplement, p.S89.
This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/
Publication date
2017
Notes
This paper was published in the journal Cytotherapy and the definitive published version is available at https://doi.org/10.1016/j.jcyt.2017.02.219. This is the abstract for a poster presented at the ISCT 2017 Annual Meeting.